{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:49:02Z","timestamp":1793922542653,"version":"4.8.0"},"reference-count":293,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA061709"],"award-info":[{"award-number":["UG3DA061709"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R41DA059296"],"award-info":[{"award-number":["R41DA059296"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA061433"],"award-info":[{"award-number":["R01DA061433"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008294","name":"Louisiana State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012612","name":"LSU Health Shreveport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM121307"],"award-info":[{"award-number":["P20GM121307"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00770","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:56:52Z","timestamp":1762307812000},"page":"e00770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems"],"prefix":"10.1016","volume":"22","author":[{"given":"Papori","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Farris","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru Mihai","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopi K.","family":"Kolluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Schmoutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumbhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadejda","family":"Korneeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Frances","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Jarrett","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsea","family":"Keys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Brackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Avadhanula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am J Psychiatr"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neurot.2025.e00770_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-030-81147-1_4","article-title":"The brain's reward system in health and disease","volume":"1344","author":"Lewis","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00770_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1242\/dmm.026120","article-title":"Rodent models in neuroscience research: is it a rat race?","volume":"9","author":"Ellenbroek","year":"2016","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol Sci"},{"issue":"5335","key":"10.1016\/j.neurot.2025.e00770_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.278.5335.63","article-title":"Psychoactive drug use in evolutionary perspective","volume":"278","author":"Nesse","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0959-4388(97)80008-6","article-title":"Neural basis of utility estimation","volume":"7","author":"Shizgal","year":"1997","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(95)00033-B","article-title":"Food reward: brain substrates of wanting and liking","volume":"20","author":"Berridge","year":"1996","journal-title":"Neurosci Biobehav Rev"},{"issue":"1-3","key":"10.1016\/j.neurot.2025.e00770_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(99)00372-6","article-title":"Drug addiction as dopamine-dependent associative learning disorder","volume":"375","author":"Di Chiara","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"5335","key":"10.1016\/j.neurot.2025.e00770_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00770_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fpsyt.2013.00072","article-title":"Addiction is a reward deficit and stress surfeit disorder","volume":"4","author":"Koob","year":"2013","journal-title":"Front Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9730467","article-title":"The role of dopamine and its dysfunction as a consequence of oxidative stress","volume":"2016","author":"Ju\u00e1rez Olgu\u00edn","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00770_bib15","series-title":"The Brain's reward system in health and disease","author":"Lewis","year":"2021"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41593-018-0152-y","article-title":"What does dopamine mean?","volume":"21","author":"Berke","year":"2018","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2018.10.001","article-title":"What is the relationship between dopamine and effort?","volume":"42","author":"Walton","year":"2019","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2013.261","article-title":"The development and maintenance of drug addiction","volume":"39","author":"Wise","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tips.2014.04.002","article-title":"Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model","volume":"35","author":"Leyton","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00770_bib21","article-title":"The neurobiology of substance use and addiction: eveidence from neuroimaging and relevance to treatment","volume":"26","author":"Alexandra Hayes","year":"2020","journal-title":"BJPsych Adv"},{"issue":"6693","key":"10.1016\/j.neurot.2025.e00770_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk6742","article-title":"Drugs of abuse hijack a mesolimbic pathway that processes homeostatic need","volume":"384","author":"Tan","year":"2024","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/bies.201000042","article-title":"Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit","volume":"32","author":"Volkow","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.neurot.2025.e00770_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fpsyt.2011.00064","article-title":"The dopamine hypothesis of drug addiction and its potential therapeutic value","volume":"2","author":"Diana","year":"2011","journal-title":"Front Psychiatr"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00770_bib25","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrn3381","article-title":"The brain reward circuitry in mood disorders","volume":"14","author":"Russo","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14030258","article-title":"Impacts of self-administered 3,4-Methylenedioxypyrovalerone (MDPV) alone, and in combination with caffeine, on recognition memory and striatal monoamine neurochemistry in Male sprague dawley rats: comparisons with methamphetamine and cocaine","volume":"14","author":"Seaman","year":"2024","journal-title":"Brain Sci"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00770_bib28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: insights from imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1016\/j.neurot.2025.e00770_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.174093","article-title":"Swiss-webster and C57BL\/6 mice are differentially sensitive to the stimulant effects of methamphetamine","volume":"256","author":"Wood","year":"2025","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/NMD.0000000000001836","article-title":"Psychiatric Comorbidities in Fibromyalgia: A Comparison With Chronic Conditions and Healthy Controls","volume":"213","author":"Avni","year":"2025","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pscychresns.2006.03.001","article-title":"Dopamine transporter binding in depressed patients with anhedonia","volume":"147","author":"Sarchiapone","year":"2006","journal-title":"Psychiatr Res Neuroimaging"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000351523","article-title":"Electrical stimulation-evoked dopamine release in the primate striatum","volume":"91","author":"Gale","year":"2013","journal-title":"Stereotact Funct Neurosurg"},{"issue":"5-6","key":"10.1016\/j.neurot.2025.e00770_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-200209000-00008","article-title":"Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies","volume":"13","author":"Volkow","year":"2002","journal-title":"Behav Pharmacol"},{"issue":"37","key":"10.1016\/j.neurot.2025.e00770_bib34","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","article-title":"Addiction: beyond dopamine reward circuitry","volume":"108","author":"Volkow","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2025.e00770_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","article-title":"Imaging dopamine's role in drug abuse and addiction","volume":"56","author":"Volkow","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.semnuclmed.2016.09.003","article-title":"Blunted dopamine transmission in addiction: potential mechanisms and implications for behavior","volume":"47","author":"Trifilieff","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopsych.2011.08.024","article-title":"Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction","volume":"71","author":"Martinez","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"0 0","key":"10.1016\/j.neurot.2025.e00770_bib38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuropharm.2013.06.031","article-title":"Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity","volume":"76 Pt B","author":"Trifilieff","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","article-title":"Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis","volume":"74","author":"Ashok","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/NMD.0000000000001836","article-title":"Psychiatric comorbidities in fibromyalgia: a comparison with chronic conditions and healthy controls","volume":"213","author":"Avni","year":"2025","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.biopsych.2014.04.017","article-title":"Blunted dopamine release as a biomarker for vulnerability for substance use disorders","volume":"76","author":"Trifilieff","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2025.e00770_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jnc.14008","article-title":"The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation","volume":"142","author":"McLaughlin","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00770_bib43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnhum.2014.00174","article-title":"The role of the habenula in drug addiction","volume":"8","author":"Velasquez","year":"2014","journal-title":"Front Hum Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib44","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1038\/s41380-025-02964-8","article-title":"The neural pathway from the superior subpart of the medial habenula to the interpeduncular nucleus suppresses anxiety","volume":"30","author":"Handa","year":"2025","journal-title":"Mol Psychiatr"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib45","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012138","article-title":"Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal","volume":"3","author":"Dani","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neurot.2025.e00770_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neubiorev.2018.06.018","article-title":"From controlled to compulsive drug-taking: the role of the habenula in addiction","volume":"106","author":"Mathis","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"Pt B","key":"10.1016\/j.neurot.2025.e00770_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuropharm.2014.11.019","article-title":"The habenulo-interpeduncular pathway in nicotine aversion and withdrawal","volume":"96","author":"Antolin-Fontes","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tips.2016.11.001","article-title":"Anxiety and nicotine dependence: emerging role of the habenulo-interpeduncular axis","volume":"38","author":"Molas","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00770_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fpsyt.2019.00100","article-title":"The role of the medial habenula cholinergic system in addiction and emotion-associated behaviors","volume":"10","author":"Lee","year":"2019","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.neurot.2025.e00770_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00238","article-title":"Medial habenula-interpeduncular nucleus circuit contributes to anhedonia-like behavior in a rat model of depression","volume":"12","author":"Xu","year":"2018","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41386-021-01107-1","article-title":"Dynamic activity of interpeduncular nucleus GABAergic neurons controls expression of nicotine withdrawal in Male mice","volume":"47","author":"Klenowski","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/neurolint14010004","article-title":"Naltrexone implant for opioid use disorder","volume":"14","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"10.1016\/j.neurot.2025.e00770_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/SAR.S362861","article-title":"Updated perspectives on the neurobiology of substance use disorders using neuroimaging","volume":"14","author":"Murnane","year":"2023","journal-title":"Subst Abuse Rehabil"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/neurolint15010021","article-title":"Transcranial stimulation for the treatment of stimulant use disorder","volume":"15","author":"Edinoff","year":"2023","journal-title":"Neurol Int"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5055\/jom.0876","article-title":"Repetitive transcranial magnetic stimulation in the treatment of opioid use disorder: a narrative review","volume":"20","author":"Edinoff","year":"2024","journal-title":"J Opioid Manag"},{"issue":"4-5","key":"10.1016\/j.neurot.2025.e00770_bib57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1037\/bne0000625","article-title":"Deep brain stimulation of nucleus basalis of meynert: effect of stimulation mode and duration on learning in rat model of dementia","volume":"139","author":"Kumbhare","year":"2025","journal-title":"Behav Neurosci"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib58","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","article-title":"Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C] raclopride","volume":"24","author":"Pruessner","year":"2004","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib59","article-title":"Historical pathways for opioid addiction, withdrawal with traditional and alternative treatment options with ketamine, cannabinoids, and noribogaine: a narrative review","volume":"10","author":"Edinoff","year":"2022","journal-title":"Health Psychol Res"},{"issue":"5479","key":"10.1016\/j.neurot.2025.e00770_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1126\/science.289.5479.591","article-title":"Dysfunction in the neural circuitry of emotion regulation--a possible prelude to violence","volume":"289","author":"Davidson","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3565(25)30973-0","article-title":"Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons","volume":"202","author":"Iwatsubo","year":"1977","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1523\/JNEUROSCI.08-01-00100.1988","article-title":"Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area","volume":"8","author":"Einhorn","year":"1988","journal-title":"J Neurosci : Off J Soc Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nn.3335","article-title":"CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors","volume":"16","author":"Wanat","year":"2013","journal-title":"Nat Neurosci"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00770_bib64","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1523\/JNEUROSCI.2814-18.2019","article-title":"Corticolimbic mechanisms of behavioral inhibition under threat of punishment","volume":"39","author":"Verharen","year":"2019","journal-title":"J Neurosci : Off J Soc Neurosci"},{"issue":"42","key":"10.1016\/j.neurot.2025.e00770_bib65","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of phasic and tonic dopamine release on receptor activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib66","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.neuron.2011.12.006","article-title":"A role for phasic dopamine neuron firing in habit learning","volume":"72","author":"Aggarwal","year":"2011","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib67","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/nn1923","article-title":"Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens","volume":"10","author":"Day","year":"2007","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib68","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00770_bib69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11010017","article-title":"The role of gamma oscillations in the pathophysiology of substance use disorders","volume":"11","author":"Ramlakhan","year":"2020","journal-title":"J Personalized Med"},{"key":"10.1016\/j.neurot.2025.e00770_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fncel.2013.00213","article-title":"Optogenetically evoked gamma oscillations are disturbed by cocaine administration","volume":"7","author":"Dilgen","year":"2013","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib72","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuropharm.2012.04.036","article-title":"Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens","volume":"63","author":"Morra","year":"2012","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00770_bib73","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tins.2003.09.016","article-title":"Interneuron diversity series: inhibitory interneurons and network oscillations in vitro","volume":"26","author":"Whittington","year":"2003","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1300.010","article-title":"NMDA receptor antagonism and the ethanol intoxication signal","volume":"1003","author":"Krystal","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00770_bib75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(92)90181-8","article-title":"Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation","volume":"598","author":"Arai","year":"1992","journal-title":"Brain Res"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00770_bib76","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024121118","article-title":"Subthalamic low-frequency oscillations predict vulnerability to cocaine addiction","volume":"118","author":"Degoulet","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neurot.2025.e00770_bib77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2010.04.050","article-title":"Hippocampal theta rhythm and drug-related reward-seeking behavior: an analysis of cocaine-induced conditioned place preference in rats","volume":"1342","author":"Takano","year":"2010","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib78","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41598-019-41568-5","article-title":"Formation of a morphine-conditioned place preference does not change the size of evoked potentials in the ventral hippocampus-nucleus accumbens projection","volume":"9","author":"Sakae","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.neubiorev.2011.10.002","article-title":"EEG Delta oscillations as a correlate of basic homeostatic and motivational processes","volume":"36","author":"Knyazev","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroimage.2009.01.058","article-title":"The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques","volume":"46","author":"Wacker","year":"2009","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib81","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.addbeh.2007.11.006","article-title":"EEG correlates of imagery-induced cigarette craving in male and female smokers","volume":"33","author":"Knott","year":"2008","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1176\/jnp.11.2.209","article-title":"The EEG and cocaine sensitization: a hypothesis","volume":"11","author":"Alper","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21307\/ane-2020-002","article-title":"Local field potential power spectra and locomotor activity following treatment with pseudoephedrine in mice","volume":"80","author":"Sa-Ih","year":"2020","journal-title":"Acta Neurobiol Exp"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48870-2","article-title":"Time-Frequency based phase-amplitude coupling measure for neuronal oscillations","volume":"9","author":"Munia","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2025.e00770_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135939","article-title":"Spectral power and theta-gamma coupling in the basolateral amygdala related with methamphetamine conditioned place preference in mice","volume":"756","author":"Nukitram","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2025.e00770_bib86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2019.02.020","article-title":"Theta-gamma coupling in the prelimbic area is associated with heroin addiction","volume":"701","author":"Zhu","year":"2019","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib87","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neuron.2018.04.015","article-title":"Cocaine place conditioning strengthens location-specific hippocampal coupling to the nucleus accumbens","volume":"98","author":"Sjulson","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00770_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1196\/annals.1441.022","article-title":"Protein kinases and addiction","volume":"1141","author":"Lee","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurot.2025.e00770_bib89","series-title":"Neurobiology of addiction: StatPearls","author":"Khan","year":"2023"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00770_bib90","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"DeltaFosB: a sustained molecular switch for addiction","volume":"98","author":"Nestler","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib91","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00213-018-4895-7","article-title":"Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder","volume":"235","author":"Wen","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib92","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.alcohol.2015.03.007","article-title":"Phosphodiesterase regulation of alcohol drinking in rodents","volume":"49","author":"Logrip","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.neurot.2025.e00770_bib93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2009.03.062","article-title":"Stress-induced dendritic remodeling in the medial prefrontal cortex: effects of circuit, hormones and rest","volume":"1293","author":"Shansky","year":"2009","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib94","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurot.2025.e00770_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1604252","article-title":"Individuals recently abstinent from methamphetamine show selective cognitive and behavioral differences when compared to age-matched controls","volume":"16","author":"Vest","year":"2025","journal-title":"Front Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib96","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5546","article-title":"Function and application of brain-derived neurotrophic factor precursors (Review)","volume":"56","author":"Chen","year":"2025","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.neurot.2025.e00770_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1876396001407010005","article-title":"Effect of brain derived neurotrophic factor, in relation to diet and lifestyle factors, for prevention of neuropsychiatric and vascular diseases and diabetes","volume":"7","author":"Singh","year":"2014","journal-title":"Open Nutraceuticals J"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040735","article-title":"Dopamine: the neuromodulator of long-term synaptic plasticity, reward and movement control","volume":"10","author":"Speranza","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib99","first-page":"1","article-title":"Dopaminergic modulation of synaptic plasticity, its role in neuropsychiatric disorders, and its computational modeling","volume":"10","author":"Madadi","year":"2019","journal-title":"Basic Clin Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib101","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib102","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/mp.2017.61","article-title":"Neuronal plasticity and neurotrophic factors in drug responses","volume":"22","author":"Castr\u00e9n","year":"2017","journal-title":"Mol Psychiatr"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib103","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1023\/A:1012775808253","article-title":"trkB-receptor activation contributes to the kainate-induced increase in BDNF mRNA synthesis","volume":"21","author":"Saarelainen","year":"2001","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib104","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ejn.14630","article-title":"Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants","volume":"53","author":"Duman","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuron.2008.06.020","article-title":"Cocaine regulates MEF2 to control synaptic and behavioral plasticity","volume":"59","author":"Pulipparacharuvil","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nn1812","article-title":"IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates","volume":"10","author":"Russo","year":"2007","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib107","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.conb.2013.03.005","article-title":"Drug-evoked synaptic plasticity: beyond metaplasticity","volume":"23","author":"Creed","year":"2013","journal-title":"Curr Opin Neurobiol"},{"issue":"7379","key":"10.1016\/j.neurot.2025.e00770_bib108","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nature10709","article-title":"Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour","volume":"481","author":"Pascoli","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib109","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1519248113","article-title":"Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement","volume":"113","author":"Hearing","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivas","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib111","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2174\/1570159X20666220114152052","article-title":"From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder","volume":"20","author":"Miuli","year":"2022","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib112","article-title":"Molecular changes in the medial prefrontal cortex and nucleus accumbens are associated with blocking the behavioral sensitization to cocaine","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00770_bib113","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00213-024-06684-9","article-title":"Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal","volume":"241","author":"Wani","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib114","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/mp.2015.223","article-title":"Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users","volume":"21","author":"Kohno","year":"2016","journal-title":"Mol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflammation"},{"issue":"5-6","key":"10.1016\/j.neurot.2025.e00770_bib116","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FBP.0000000000000080","article-title":"Drug withdrawal conceptualized as a stressor","volume":"25","author":"Chartoff","year":"2014","journal-title":"Behav Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2025.e00770_bib117","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139","author":"DiSabato","year":"2016","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020184","article-title":"Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release","volume":"8","author":"Mahmoud","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00770_bib119","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib120","article-title":"From synapses to circuits, astrocytes regulate behavior","volume":"15","author":"Lyon","year":"2021","journal-title":"Front Neural Circ"},{"key":"10.1016\/j.neurot.2025.e00770_bib121","first-page":"256","article-title":"Astrocytic G protein-coupled receptors in drug addiction","volume":"44","author":"Zinsmaier","year":"2025","journal-title":"Engineering (Beijing)"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00770_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168610","article-title":"Control of dopamine signal in high-order receptor complex on striatal astrocytes","volume":"25","author":"Amato","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib123","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.biopsych.2025.02.904","article-title":"Astrocytes control cocaine-induced synaptic plasticity and reward through the matricellular protein hevin","volume":"98","author":"Mongr\u00e9dien","year":"2025","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib124","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.116.238501","article-title":"Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment","volume":"362","author":"Moszczynska","year":"2017","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.neurot.2025.e00770_bib125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pneurobio.2015.09.011","article-title":"Amphetamine-related drugs neurotoxicity in humans and in experimental animals: main mechanisms","volume":"155","author":"Moratalla","year":"2017","journal-title":"Prog Neurobiol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41593-019-0361-z","article-title":"Distinct hippocampal engrams control extinction and relapse of fear memory","volume":"22","author":"Lacagnina","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib127","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2025.e00770_bib128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2018.04.037","article-title":"The relationship between interleukin-6 and functional connectivity in methamphetamine users","volume":"677","author":"Kohno","year":"2018","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuron.2017.09.021","article-title":"Synaptic transmission optimization predicts expression loci of long-term plasticity","volume":"96","author":"Costa","year":"2017","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00770_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.352","article-title":"Striatal activity and reduced white matter increase frontal activity in youths with family histories of alcohol and other substance-use disorders performing a go\/no-go task","volume":"5","author":"Acheson","year":"2015","journal-title":"Brain and behavior"},{"key":"10.1016\/j.neurot.2025.e00770_bib131","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1196\/annals.1369.020","article-title":"Alterations in blood-brain barrier function by morphine and methamphetamine","volume":"1074","author":"Sharma","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib132","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neuroscience.2009.04.004","article-title":"Permeability of the blood-brain barrier depends on brain temperature","volume":"161","author":"Kiyatkin","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2025.e00770_bib133","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ibneur.2022.08.004","article-title":"Alcoholic neuropathy associated with chronic alcohol intake","volume":"13","author":"Tessitore","year":"2022","journal-title":"IBRO Neuroscience Reports"},{"key":"10.1016\/j.neurot.2025.e00770_bib134","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fphar.2012.00121","article-title":"The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation","volume":"3","author":"Kousik","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00770_bib135","article-title":"Oxidative stress profiles of lymphoblasts from amyotrophic lateral sclerosis patients with or without known SOD1 mutations","volume":"2022","author":"Cunha-Oliveira","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.neurot.2025.e00770_bib136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2015.06.014","article-title":"Chronic intermittent ethanol induced axon and myelin degeneration is attenuated by calpain inhibition","volume":"1622","author":"Samantaray","year":"2015","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib137","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/pathophysiology30020013","article-title":"Methamphetamine and designer stimulants modulate tonic human cerebrovascular smooth muscle contractility: relevance to drug-induced neurovascular stress","volume":"30","author":"Hall","year":"2023","journal-title":"Pathophysiology"},{"key":"10.1016\/j.neurot.2025.e00770_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00513","article-title":"Effects of drugs of abuse on the blood-brain barrier: a brief overview","volume":"14","author":"Pimentel","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib139","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fnmol.2018.00186","article-title":"The main molecular mechanisms underlying Methamphetamine- induced neurotoxicity and implications for pharmacological treatment","volume":"11","author":"Yang","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2009.03.002","article-title":"Methamphetamine toxicity and messengers of death","volume":"60","author":"Krasnova","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neurot.2025.e00770_bib141","article-title":"Early onset cardiovascular disease related to methamphetamine use is Most striking in individuals under 30: a retrospective chart review","volume":"15","author":"Batra","year":"2022","journal-title":"Addict Behav Rep"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib142","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1139\/jpn.0635","article-title":"The need for speed: an update on methamphetamine addiction","volume":"31","author":"Barr","year":"2006","journal-title":"J Psychiatry Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib143","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2016.04.012","article-title":"Fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [(11)C]CURB","volume":"80","author":"Boileau","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib144","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","article-title":"Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain","volume":"35","author":"Cosenza-Nashat","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"51","key":"10.1016\/j.neurot.2025.e00770_bib145","doi-asserted-by":"crossref","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","article-title":"Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors","volume":"285","author":"Takata","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib146","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2008.10.034","article-title":"Decreased brain dopamine cell numbers in human cocaine users","volume":"168","author":"Little","year":"2009","journal-title":"Psychiatry Res"},{"issue":"8310","key":"10.1016\/j.neurot.2025.e00770_bib147","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(82)90101-5","article-title":"Leucoencephalopathy after inhaling \"heroin\" pyrolysate","volume":"2","author":"Wolters","year":"1982","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib148","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/schbul\/sbq079","article-title":"The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample","volume":"38","author":"Y\u00fccel","year":"2012","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib149","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MJT.0b013e31820b8856","article-title":"\u2018Chasing the dragon\u2019: new knowledge for an old practice","volume":"21","author":"Cordova","year":"2014","journal-title":"Am J Therapeut"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3174\/ajnr.A1889","article-title":"Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings","volume":"31","author":"Salgado","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib151","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12028-010-9373-y","article-title":"Severe leukoencephalopathy following acute oxycodone intoxication","volume":"13","author":"Morales Odia","year":"2010","journal-title":"Neurocritical Care"},{"issue":"Pt 7","key":"10.1016\/j.neurot.2025.e00770_bib152","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/brain\/awq138","article-title":"Alterations in brain structure and functional connectivity in prescription opioid-dependent patients","volume":"133","author":"Upadhyay","year":"2010","journal-title":"Brain"},{"issue":"1-3","key":"10.1016\/j.neurot.2025.e00770_bib153","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejphar.2004.07.036","article-title":"Opioid abuse and brain gene expression","volume":"500","author":"Przewlocki","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011278","article-title":"Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling","volume":"5","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00770_bib155","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1523\/JNEUROSCI.5129-07.2008","article-title":"Glutamate release in the nucleus accumbens core is necessary for heroin seeking","volume":"28","author":"LaLumiere","year":"2008","journal-title":"J Neurosci : Off J Soc Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib156","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12868-020-0552-2","article-title":"Carbonyl-protein content increases in brain and blood of female rats after chronic oxycodone treatment","volume":"21","author":"Fan","year":"2020","journal-title":"BMC Neurosci"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00770_bib157","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1523\/JNEUROSCI.22-17-07650.2002","article-title":"Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism","volume":"22","author":"Mao","year":"2002","journal-title":"J Neurosci : Off J Soc Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14030302","article-title":"Roles of oxidative stress and autophagy in alcohol-mediated brain damage","volume":"14","author":"Ruiter-Lopez","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00770_bib159","series-title":"Brain damage - bridging between basic research and clinics","article-title":"Cognitive impairments in drug addicts","author":"Nyberg","year":"2012"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/alcalc\/agt164","article-title":"Neuroimmune activation and myelin changes in adolescent rats exposed to high-dose alcohol and associated cognitive dysfunction: a review with reference to human adolescent drinking","volume":"49","author":"Pascual","year":"2014","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib161","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jnr.24203","article-title":"Role of the innate immune system in the neuropathological consequences induced by adolescent binge drinking","volume":"96","author":"Pascual","year":"2018","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurot.2025.e00770_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.643273","article-title":"Impact of alcohol abuse on susceptibility to rare neurodegenerative diseases","volume":"8","author":"Araujo","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib163","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbi.2023.02.020","article-title":"Chronic ethanol induces a pro-inflammatory switch in interleukin-1\u03b2 regulation of GABAergic signaling in the medial prefrontal cortex of male mice","volume":"110","author":"Varodayan","year":"2023","journal-title":"Brain Behav Immun"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00770_bib164","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1523\/JNEUROSCI.0976-10.2010","article-title":"Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage","volume":"30","author":"Alfonso-Loeches","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jnc.12276","article-title":"Ethanol induces TLR4\/TLR2 association, triggering an inflammatory response in microglial cells","volume":"126","author":"Fernandez-Lizarbe","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00770_bib166","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2015.12.006","article-title":"Involvement of TLR4 in the long-term epigenetic changes, rewarding and anxiety effects induced by intermittent ethanol treatment in adolescence","volume":"53","author":"Montesinos","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00770_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108698","article-title":"Alcohol drinking during early adolescence activates microglial cells and increases frontolimbic Interleukin-1 beta and toll-like receptor 4 gene expression, with heightened sensitivity in male rats compared to females","volume":"197","author":"Silva-Gotay","year":"2021","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00770_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9070167","article-title":"Sex differences in the effect of alcohol drinking on myelinated axons in the anterior cingulate cortex of adolescent rats","volume":"9","author":"Tavares","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurot.2025.e00770_bib169","article-title":"Ethanol drinking sex-dependently alters cortical IL-1\u03b2 synaptic signaling and cognitive behavior in mice","author":"Liss","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.neurot.2025.e00770_bib170","series-title":"Comparisons with methamphetamine and cocaine","article-title":"Impacts of self-administered 3,4-Methylenedioxypyrovalerone (MDPV) alone, and in combination with caffeine, on recognition memory and striatal monoamine neurochemistry in Male sprague-dawley rats","author":"Seaman","year":"2024"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib171","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/FBP.0000000000000548","article-title":"The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats","volume":"31","author":"Hyatt","year":"2020","journal-title":"Behav Pharmacol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00770_bib172","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/mp.2014.177","article-title":"DAT isn't all that: cocaine reward and reinforcement require toll-like receptor 4 signaling","volume":"20","author":"Northcutt","year":"2015","journal-title":"Mol Psychiatr"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00770_bib173","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib174","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1021\/acschemneuro.9b00225","article-title":"Methamphetamine activates toll-like receptor 4 to induce central immune signaling within the ventral tegmental area and contributes to extracellular dopamine increase in the nucleus Accumbens shell","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","article-title":"Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies","volume":"179","author":"Kohno","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neurot.2025.e00770_bib176","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-420118-7.00002-0","article-title":"The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse","volume":"69","author":"Nickell","year":"2014","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00770_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1587222","article-title":"Implications and pathophysiology of neuroinflammation in pediatric patients with traumatic brain injury: an updated review","volume":"19","author":"Shah","year":"2025","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.joep.2018.12.001","article-title":"An exercise in self-replication: replicating Shah, Mullainathan, and Shafir (2012)","volume":"75","author":"Shah","year":"2019","journal-title":"J Econ Psychol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib179","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1750-3639.2004.tb00079.x","article-title":"Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes","volume":"14","author":"Vall\u00e9s","year":"2004","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2004.01.010","article-title":"Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity","volume":"187","author":"LaVoie","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00770_bib181","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1054-3589(08)60910-2","article-title":"Circuits, drugs, and drug addiction","volume":"42","author":"Koob","year":"1998","journal-title":"Adv Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib182","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2003.09.009","article-title":"Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia","volume":"46","author":"Mizuno","year":"2004","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib183","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41569-022-00741-6","article-title":"Sulfide regulation of cardiovascular function in health and disease","volume":"20","author":"Kolluru","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib184","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.redox.2013.05.001","article-title":"A tale of two gases: NO and H2S, foes or friends for life?","volume":"1","author":"Kolluru","year":"2013","journal-title":"Redox Biol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib185","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib186","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/152308603768295249","article-title":"The gasotransmitter role of hydrogen sulfide","volume":"5","author":"Wang","year":"2003","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.neurot.2025.e00770_bib187","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jare.2021.08.012","article-title":"Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders","volume":"38","author":"Wang","year":"2022","journal-title":"J Adv Res"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib188","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/alz.12305","article-title":"Plasma hydrogen sulfide: a biomarker of Alzheimer's disease and related dementias","volume":"17","author":"Disbrow","year":"2021","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurot.2025.e00770_bib189","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1689341","article-title":"Role of gasotransmitters in oxidative stresses, neuroinflammation, and neuronal repair","volume":"2017","author":"Shefa","year":"2017","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12951-024-02523-3","article-title":"Recent advances in the application of gasotransmitters in spinal cord injury","volume":"22","author":"Gao","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib191","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13050504","article-title":"Modulating nitric oxide: implications for cytotoxicity and cytoprotection","volume":"13","author":"Belenichev","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00770_bib192","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bcp.2017.11.019","article-title":"Gasotransmitter hydrogen sulfide signaling in neuronal health and disease","volume":"149","author":"Paul","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"68","key":"10.1016\/j.neurot.2025.e00770_bib193","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.268re2","article-title":"Signaling by gasotransmitters","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.neurot.2025.e00770_bib194","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu Rev Biochem"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00770_bib195","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1111\/bph.14800","article-title":"Nitric oxide signalling in the brain and its control of bodily functions","volume":"177","author":"Chachlaki","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib196","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s12264-023-01060-7","article-title":"nNOS and neurological, neuropsychiatric disorders: a 20-Year story","volume":"39","author":"Zhu","year":"2023","journal-title":"Neurosci Bull"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib197","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/ars.2008.2234","article-title":"Nitric oxide in health and disease of the nervous system","volume":"11","author":"Knott","year":"2009","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.neurot.2025.e00770_bib198","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1824713","article-title":"Roles of gasotransmitters in synaptic plasticity and neuropsychiatric conditions","volume":"2018","author":"Shefa","year":"2018","journal-title":"Neural Plast"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib199","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/18756190MTA2pMjApy","article-title":"Role of nitric oxide in neurodegeneration: function, regulation, and inhibition","volume":"19","author":"Tewari","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.neurot.2025.e00770_bib200","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1103416","article-title":"Microglia activation in central nervous system disorders: a review of recent mechanistic investigations and development efforts","volume":"14","author":"Qin","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2025.e00770_bib201","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2023.11.014","article-title":"Strategies for gaseous neuromodulator release in chemical neuroscience: experimental approaches and translational validation","volume":"365","author":"Ali","year":"2024","journal-title":"J Contr Release"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib202","first-page":"1688","article-title":"The activation of BDNF reduced inflammation in a spinal cord injury model by TrkB\/p38 MAPK signaling","volume":"17","author":"Liang","year":"2019","journal-title":"Exp Ther Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib203","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies","volume":"157","author":"Duda","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurot.2025.e00770_bib204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fncel.2017.00066","article-title":"Neuronal nitric oxide synthase in neural stem cells induces neuronal fate commitment via the inhibition of histone deacetylase 2","volume":"11","author":"Jin","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"6295","key":"10.1016\/j.neurot.2025.e00770_bib205","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/347768a0","article-title":"Localization of nitric oxide synthase indicating a neural role for nitric oxide","volume":"347","author":"Bredt","year":"1990","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib206","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s12264-023-01060-7","article-title":"nNOS and neurological, neuropsychiatric disorders: a 20-Year story","volume":"39","author":"Zhu","year":"2023","journal-title":"Neurosci Bull"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib207","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41531-022-00370-3","article-title":"Nitrosative stress in Parkinson's disease","volume":"8","author":"Stykel","year":"2022","journal-title":"npj Parkinson's Dis"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib208","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/jcbfm.2011.127","article-title":"Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence","volume":"31","author":"Vivien","year":"2011","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib209","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/STROKEAHA.106.478826","article-title":"Nitric oxide synthase isoforms undertake unique roles during excitotoxicity","volume":"38","author":"Parathath","year":"2007","journal-title":"Stroke"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00770_bib210","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1177\/1535370221997052","article-title":"Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells","volume":"246","author":"Liy","year":"2021","journal-title":"Exp Biol Med"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/157015912804499465","article-title":"Neuronal-glial interactions define the role of nitric oxide in neural functional processes","volume":"10","author":"Contestabile","year":"2012","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.niox.2010.06.001","article-title":"Nitric oxide and neuronal death","volume":"23","author":"Brown","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.neurot.2025.e00770_bib213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.niox.2023.03.003","article-title":"Dual role of nitric oxide in Alzheimer's disease","volume":"134\u2013135","author":"Azargoonjahromi","year":"2023","journal-title":"Nitric Oxide"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib214","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib215","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005710","article-title":"NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD)","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"6273","key":"10.1016\/j.neurot.2025.e00770_bib216","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/345346a0","article-title":"Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter","volume":"345","author":"Bult","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00770_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105071","article-title":"NMDA receptors sustain but do not initiate neuronal depolarization in spreading depolarization","volume":"145","author":"Mei","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00770_bib218","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1523\/JNEUROSCI.21-17-06480.2001","article-title":"Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity","volume":"21","author":"Bal-Price","year":"2001","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib219","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1471-4159.2002.00973.x","article-title":"Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression","volume":"82","author":"Golde","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00770_bib220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.niox.2018.05.007","article-title":"Role of neuronal nitric oxide synthase in slowly progressive dopaminergic neurodegeneration in the Zitter rat","volume":"78","author":"Ehara","year":"2018","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib221","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/ars.2012.5119","article-title":"Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase\/cAMP pathway","volume":"20","author":"Yang","year":"2014","journal-title":"Antioxidants Redox Signal"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051095","article-title":"Protective roles of hydrogen sulfide in Alzheimer's Disease and traumatic brain injury","volume":"12","author":"Paul","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00770_bib223","article-title":"Hydrogen sulfide signalling in neurodegenerative diseases","author":"Tripathi","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib224","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuint.2013.09.003","article-title":"Physiological role of hydrogen sulfide and polysulfide in the central nervous system","volume":"63","author":"Kimura","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neurot.2025.e00770_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102633","article-title":"Elevated plasma sulfides are associated with cognitive dysfunction and brain atrophy in human Alzheimer's disease and related dementias","volume":"62","author":"Reekes","year":"2023","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib226","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44877-y","article-title":"Hydrogen sulfide and polysulfides induce GABA\/glutamate\/D-serine release, facilitate hippocampal LTP, and regulate behavioral hyperactivity","volume":"13","author":"Furuie","year":"2023","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00770_bib227","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1074\/jbc.M114.625053","article-title":"Cystathionine is a novel substrate of cystine\/glutamate transporter: implications for immune function","volume":"290","author":"Kobayashi","year":"2015","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib228","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12091737","article-title":"Hydrogen sulfide: an emerging regulator of oxidative stress and cellular Homeostasis-A comprehensive one-year review","volume":"12","author":"Munteanu","year":"2023","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib229","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib230","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459025","article-title":"The role of PI3K signaling pathway in Alzheimer's disease","volume":"16","author":"Pan","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurot.2025.e00770_bib231","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbi.2018.07.005","article-title":"Hydrogen sulfide inhibits ATP-induced neuroinflammation and A\u03b21\u201342 synthesis by suppressing the activation of STAT3 and cathepsin S","volume":"73","author":"Cao","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib232","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017225118","article-title":"Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3\u03b2 and inhibiting Tau hyperphosphorylation","volume":"118","author":"Giovinazzo","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib233","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051105","article-title":"Reactive Sulfur species omics analysis in the brain tissue of the 5xFAD mouse model of Alzheimer's Disease","volume":"12","author":"Kinno","year":"2023","journal-title":"Antioxidants"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00770_bib234","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.4161\/15384101.2014.950538","article-title":"Neurodegeneration in Huntington's disease involves loss of cystathionine \u03b3-lyase","volume":"13","author":"Paul","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neurot.2025.e00770_bib235","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fphar.2017.00608","article-title":"H(2)S-Induced sulfhydration: biological function and detection methodology","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00770_bib236","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.3390\/ijms24076014","article-title":"The role of gasotransmitter-dependent signaling mechanisms in apoptotic cell death in cardiovascular, rheumatic, kidney, and neurodegenerative diseases and mental disorders","volume":"24","author":"Rodkin","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib237","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12888","article-title":"Significant, replicable, and functional associations between KTN1 variants and alcohol and drug codependence","volume":"26","author":"Luo","year":"2021","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib238","article-title":"Cocaine and opioid-induced acute liver injury: a rare case report","volume":"14","author":"Dolkar","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib239","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12958","article-title":"Closing the brain\u2013heart loop: towards more holistic models of addiction and addiction recovery","volume":"27","author":"Eddie","year":"2022","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib240","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/acer.14765","article-title":"Abstinence versus moderation recovery pathways following resolution of a substance use problem: prevalence, predictors, and relationship to psychosocial well-being in a U.S. national sample","volume":"46","author":"Eddie","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib241","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40429-021-00379-3","article-title":"Substance use and addiction affect more than the brain: the promise OF neurocardiac interventions","volume":"8","author":"Eddie","year":"2021","journal-title":"Curr Addict Rep"},{"key":"10.1016\/j.neurot.2025.e00770_bib242","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.copsyc.2019.03.008","article-title":"Theoretical implications and clinical support for heart rate variability biofeedback for substance use disorders","volume":"30","author":"Leyro","year":"2019","journal-title":"Curr Opin Psychol"},{"issue":"5-6","key":"10.1016\/j.neurot.2025.e00770_bib243","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00429-010-0268-7","article-title":"The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making","volume":"214","author":"Naqvi","year":"2010","journal-title":"Brain Struct Funct"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib244","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10484-020-09466-z","article-title":"Heart rate variability biofeedback improves emotional and physical health and performance: a systematic review and Meta analysis","volume":"45","author":"Lehrer","year":"2020","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib245","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1037\/adb0000524","article-title":"Improvement in women's cardiovascular functioning during cognitive-behavioral therapy for alcohol use disorder","volume":"33","author":"Buckman","year":"2019","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib246","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/19417381211056088","article-title":"Developmental training model for the sport specialized youth athlete: a dynamic strategy for individualizing load-response during maturation","volume":"14","author":"Jayanthi","year":"2022","journal-title":"Sport Health"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib247","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine Use and Cardiovascular Disease","volume":"39","author":"Kevil","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib248","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.chest.2024.01.014","article-title":"Overview of methamphetamine-associated pulmonary arterial hypertension","volume":"165","author":"Charoenpong","year":"2024","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib249","article-title":"Methamphetamine use: a narrative review of adverse effects and related toxicities","volume":"10","author":"Edinoff","year":"2022","journal-title":"Health Psychol Res"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib250","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/heartjnl-2020-318856","article-title":"Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young","volume":"107","author":"Scott","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.neurot.2025.e00770_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/frhs.2022.1053496","article-title":"Reflections on 10 years of effectiveness-implementation hybrid studies","volume":"2","author":"Curran","year":"2022","journal-title":"Front Health Serv"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib252","article-title":"Effects of substance use disorder on In-Hospital outcomes of young patients presenting with a cardiovascular event: a nationwide analysis","volume":"14","author":"Brgdar","year":"2022","journal-title":"Cureus"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00770_bib253","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/bjsports-2020-102666","article-title":"Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study","volume":"55","author":"Peterson","year":"2021","journal-title":"Br J Sports Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib254","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11936-019-0724-5","article-title":"Psychosocial stress and cardiovascular disease","volume":"21","author":"Dar","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib256","first-page":"27","article-title":"Cardiovascular disease risk factors in the native American population","volume":"12","author":"Goerger","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib257","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11886-019-1222-9","article-title":"Sense of purpose in life and cardiovascular disease: underlying mechanisms and future directions","volume":"21","author":"Kim","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.neurot.2025.e00770_bib258","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugalcdep.2017.07.006","article-title":"The importance of nutrition in aiding recovery from substance use disorders: a review","volume":"179","author":"Jeynes","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00770_bib259","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/1871527321666220511145230","article-title":"Elucidating the role of trauma and significant life stress in the disease of addiction May provide new targets for medication development","volume":"22","author":"Sagrera","year":"2023","journal-title":"CNS Neurol Disord: Drug Targets"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib260","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/npp.2013.306","article-title":"Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity","volume":"39","author":"Halpin","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"38","key":"10.1016\/j.neurot.2025.e00770_bib261","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2530-12.2012","article-title":"Peripheral Ammonia as a Mediator of methamphetamine neurotoxicity","volume":"32","author":"Halpin","year":"2012","journal-title":"J Neurosci"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00770_bib262","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuint.2005.04.004","article-title":"Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes","volume":"47","author":"Rama Rao","year":"2005","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib263","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ijc.30678","article-title":"Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis of published data","volume":"141","author":"Wang","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neurot.2025.e00770_bib264","article-title":"Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib265","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.8","article-title":"Methamphetamine causes acute hyperthermia-dependent liver damage","volume":"1","author":"Halpin","year":"2013","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.neurot.2025.e00770_bib266","article-title":"S3504 Cocaine-Induced hepatotoxicity (CIN): still a clinical mystery til this day","volume":"115","author":"Novikov","year":"2020","journal-title":"Official journal of the American College of Gastroenterology | ACG"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib267","first-page":"34","article-title":"Liver disorders in substance abusers","volume":"6","author":"Zacharia","year":"2025","journal-title":"Hepatol Forum"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib268","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8030050","article-title":"Alcohol metabolizing enzymes, microsomal ethanol oxidizing System, cytochrome P450 2E1, catalase, and aldehyde dehydrogenase in alcohol-associated liver disease","volume":"8","author":"Jiang","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2025.e00770_bib269","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.toxrep.2021.02.010","article-title":"Alcohol-associated liver disease: a review on its pathophysiology, diagnosis and drug therapy","volume":"8","author":"Subramaniyan","year":"2021","journal-title":"Toxicol Rep"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib270","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6040106","article-title":"Alcoholic liver disease: alcohol metabolism, Cascade of molecular mechanisms, cellular targets, and clinical aspects","volume":"6","author":"Teschke","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2025.e00770_bib271","article-title":"Blockade of \u03b2-Adrenergic receptors by propranolol disrupts reconsolidation of drug memory and attenuates heroin seeking","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib272","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00213-013-3039-3","article-title":"A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans","volume":"226","author":"Saladin","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00770_bib273","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/FBP.0000000000000742","article-title":"Propranolol blocks the unconditioned and conditioned hyperactive effects of methamphetamine in CD-1 mice","volume":"34","author":"Rauhut","year":"2023","journal-title":"Behav Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib274","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030854","article-title":"Noradrenergic \u03b11 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial","volume":"7","author":"Newton","year":"2012","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00770_bib275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2012.11.021","article-title":"The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: a pilot study","volume":"131","author":"Shorter","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib276","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41386-023-01696-z","article-title":"Repurposing anti-inflammatory medications for alcohol and substance use disorders","volume":"49","author":"Ozburn","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00770_bib277","article-title":"Mechanisms of GLP-1 in modulating craving and addiction: neurobiological and translational insights","volume":"13","author":"Amorim Moreira Alves","year":"2025","journal-title":"Med Sci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00770_bib278","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bph.15677","article-title":"The role of glucagon-like peptide 1 (GLP-1) in addictive disorders","volume":"179","author":"Klausen","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00770_bib279","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115338","article-title":"GLP-1 analogues in the neurobiology of addiction: translational insights and therapeutic perspectives","volume":"26","author":"Marquez-Meneses","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00770_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107312","article-title":"IUPHAR review - glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target","volume":"207","author":"Bruns Vi","year":"2024","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib281","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/jamapsychiatry.2024.3599","article-title":"Repurposing semaglutide and liraglutide for alcohol use disorder","volume":"82","author":"L\u00e4hteenvuo","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00770_bib282","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35247","article-title":"Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00770_bib283","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/s41380-024-02498-5","article-title":"Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study","volume":"29","author":"Wang","year":"2024","journal-title":"Mol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib284","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","article-title":"Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib285","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/add.16626","article-title":"GLP-1R agonist medications for addiction treatment","volume":"120","author":"Volkow","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.neurot.2025.e00770_bib286","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1191903","article-title":"Ketogenic diet: a potential adjunctive treatment for substance use disorders","volume":"10","author":"Kong","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib287","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13989","article-title":"The neurobiology of addiction","volume":"1451","author":"Uhl","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib288","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1521-0391.2013.00314.x","article-title":"Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine","volume":"22","author":"Orson","year":"2013","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib289","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.20230828","article-title":"Vaccines as immunotherapies for substance use disorders","volume":"181","author":"Kosten","year":"2024","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00770_bib290","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00770_bib291","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11916-023-01105-6","article-title":"The use of oxytocin for the treatment of opioid use disorder","volume":"27","author":"Edinoff","year":"2023","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neurot.2025.e00770_bib292","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1123424","article-title":"Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder","volume":"14","author":"Brett","year":"2023","journal-title":"Front Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00770_bib293","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/neurolint14010015","article-title":"Oxytocin, a novel treatment for methamphetamine use disorder","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792500248X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792500248X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:05:30Z","timestamp":1773291930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792500248X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":293,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S187874792500248X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00770","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00770"}}